EP Patent

EP3673897A1 — Injectable pharmaceutical composition containing meloxicam, and preparation method therefor

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2020-07-01 · 6y expired

What this patent protects

An injectable pharmaceutical composition containing meloxicam, and a preparation method therefor. The pharmaceutical composition comprises meloxicam nanoparticles, a surface stabilizer, and a sedimentation inhibiting agent. The pharmaceutical composition has good stability, is no…

USPTO Abstract

An injectable pharmaceutical composition containing meloxicam, and a preparation method therefor. The pharmaceutical composition comprises meloxicam nanoparticles, a surface stabilizer, and a sedimentation inhibiting agent. The pharmaceutical composition has good stability, is not easy to settle, and is applicable to industrial large-scale production.

Drugs covered by this patent

Patent Metadata

Patent number
EP3673897A1
Jurisdiction
EP
Classification
—
Expires
2020-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.